The Fall Of The Israeli Lobby Has Begun

Who Profited The Most From The COVID-19 Vaccine Roll Out - Several investment groups and individuals reaped substantial profits from the rollout of COVID-19 mRNA vaccines, particularly those associated with Moderna and Pfizer/BioNTech.

Key Beneficiaries of the mRNA Vaccine Rollout

1. Flagship Pioneering

This venture capital firm, led by Noubar Afeyan, co-founded Moderna and was its largest early investor. Flagship Pioneering’s substantial stake in Moderna yielded significant returns as the company’s stock surged during the pandemic.

2. Institutional Investors

Major investment firms such as Baillie Gifford & Co., Vanguard Group Inc., and BlackRock Inc. held significant shares in Moderna. As Moderna’s stock price increased dramatically—from under $20 to nearly $160 by the end of 2020—these institutions realized considerable gains.

3. AstraZeneca

Initially investing approximately $290 million in Moderna, AstraZeneca sold its entire 7.65% stake in the company for over $1 billion amid the vaccine rollout, capitalizing on the surge in Moderna’s stock price.

4. Moderna and Pfizer Executives

Executives at both companies profited by strategically selling shares timed with positive clinical trial announcements. For instance, Moderna’s CEO, Stéphane Bancel, and other top executives sold shares during periods of stock price increases, leading to substantial personal gains.

5. Select Shareholders During Variant Surges

The emergence of variants like Omicron led to spikes in vaccine manufacturer stock prices. A small group of investors and executives from Pfizer and Moderna saw their combined wealth increase by over $10 billion during such periods.

6. BioNTech and Its Investors

BioNTech, Pfizer’s partner in developing the mRNA vaccine, reported over €10 billion in profits in 2021. The company’s success also brought significant tax revenues to its home city of Mainz, Germany.

Summary

The mRNA vaccine rollout not only played a crucial role in combating the COVID-19 pandemic but also generated substantial financial gains for various investment groups and individuals. Early investors, institutional stakeholders, pharmaceutical companies, and their executives capitalized on the unprecedented demand and success of these vaccines, leading to significant profits.

VRIL AND THULE SOCIETY, ANTARCTICA, ADVANCED CIVILIZATIONS, HOLLOW EARTH, ET'S

RARE DOCUMENTARY

https://rumble.com/v3fniju-vril-and-thule-society-antarctica-advanced-civilizations-hollow-earth-ets.html

Grandpa Tom Trefts Open Challenge To Debate Dr. Oz ~ https://rumble.com/v1r6x7u-open-debate-challenge-to-dr.-oz.html